263rd ENMC International Workshop: Focus on female carriers of dystrophinopathy: refining recommendations for prevention, diagnosis, surveillance, and treatment. Hoofddorp, The Netherlands, 13-15 May 2022
Publikation: Bidrag til tidsskrift › Konferenceartikel › Forskning › fagfællebedømt
Originalsprog | Engelsk |
---|---|
Tidsskrift | Neuromuscular Disorders |
Vol/bind | 33 |
Udgave nummer | 3 |
Sider (fra-til) | 274-284 |
Antal sider | 11 |
ISSN | 0960-8966 |
DOI | |
Status | Udgivet - 2023 |
Begivenhed | 263rd ENMC International Workshop - Hoofddorp, Holland Varighed: 13 maj 2022 → 15 maj 2022 |
Workshop
Workshop | 263rd ENMC International Workshop |
---|---|
Land | Holland |
By | Hoofddorp |
Periode | 13/05/2022 → 15/05/2022 |
Bibliografisk note
Funding Information:
The workshop was made possible thanks to the financial support of the European Neuromuscular Centre (ENMC) and ENMC main sponsors: Association Française contre les Myopathies (France) , Deutsche Gesellschaft für Muskelkranke (Germany) , Muscular Dystrophy Campaign (UK) , Muskelsvindfonden (Denmark) , Prinses Beatrix Fonds (The Netherlands) , Schweizerische Stiftung für die Erforschung der Muskelkrankheiten (Switzerland) , Telethon Foundation (Italy) , Spierziekten Nederland (The Netherlands) , and Associated members Partners: Finnish Neuromuscular Association (Finland) , Österreichische Muskelforschung (Austria) , SMA Europe and World Duchenne Organisation . In addition, we would like to thank the members of the ENMC Company Forum: Sanofi, Roche, Lupin Neuroscience, Amicus Therapeutics, Ionis Pharmaceuticals, Biogen, Novartis, PerkinElmer and Astellas.
ID: 367301955